• Mexedia’s stake in Telvantis fell to 49% from 75% following Telvantis’ acquisition of AmeriCrew operating entities.
• The dilution came from Telvantis issuing Series G Voting Convertible Preferred Stock to AmeriCrew members; Mexedia did not sell shares.
• The drop below 50% ends Mexedia’s control; Telvantis will no longer be fully consolidated, cutting reported revenue and balance-sheet size.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mexedia S.p.A. Società Benefit published the original content used to generate this news brief on June 23, 2026, and is solely responsible for the information contained therein.